DXCM
DexCom IncNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$27.82B
P/E Ratio
30.94
EPS
$2.33
Beta
1.40
52W High
$89.98
52W Low
$54.11
50-Day MA
$63.32
200-Day MA
$67.98
Dividend Yield
—
Profit Margin
19.30%
Forward P/E
28.09
PEG Ratio
1.34
About DexCom Inc
DexCom, Inc. is a company that develops, manufactures, and distributes continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with headquarters in San Diego, California, and has a manufacturing facility in Mesa, Arizona.
Fundamentals
| Revenue (TTM) | $4.82B |
| Gross Profit (TTM) | $2.96B |
| EBITDA | $1.29B |
| Operating Margin | 21.40% |
| Return on Equity | 35.60% |
| Return on Assets | 9.65% |
| Revenue/Share (TTM) | $12.39 |
| Book Value | $7.66 |
| Price-to-Book | 9.38 |
| Price-to-Sales (TTM) | 5.77 |
| EV/Revenue | 5.54 |
| EV/EBITDA | 18.06 |
| Quarterly Earnings Growth (YoY) | 92.20% |
| Quarterly Revenue Growth (YoY) | 15.00% |
| Shares Outstanding | $385.87M |
| Float | $384.08M |
| % Insiders | 0.28% |
| % Institutions | 102.69% |
Historical Volatility
HV 10-Day
59.08%
HV 20-Day
50.55%
HV 30-Day
46.09%
HV 60-Day
39.82%
HV Rank
70.2%
Volatility is currently expanding
Analyst Ratings
Consensus ($81.64 target)
4
Strong Buy20
Buy2
Hold1
Strong SellMore HEALTHCARE Stocks
Data last updated: 5/25/2026